Dr. Boland began his postdoctoral studies in Kristin Baldwin’s laboratory at TSRI where he and a team of researchers were the first to generate adult mice from induced pluripotent stem cells (iPSCs) by tetraploid embryo complementation. Since joining Jeanne Loring’s laboratory, also at TSRI, he has developed patient-derived iPSC models of multiple autism spectrum disorders in order to understand the genetic and epigenetic influence on neurogenesis and neurodevelopmental disease. He received a Ph.D. in Biochemistry/Molecular Biology from the University of Nebraska Medical Center in 2007. His dissertation research focused on the characterization of a novel link between de novo DNA methylation and DNA repair in embryonic stem cells.